Alumis ALMS
NASDAQ ALMS
$7.21 -0.18 (-2.44%)
At close: Oct 1, 2026 · 4:00 PM EDT

Alumis (ALMS) EBIT (2023 - 2026)

Updated

Alumis (ALMS) posted EBIT of -$148.86 million for Q2 2026, compared with -$140.54 million a year earlier.

Analysis

Alumis (ALMS) EBIT (2023 - 2026) Analysis & Trends

For the trailing twelve months through Jun 30, 2026, EBIT at Alumis was -$501.13 million; for FY2025, it was -$453.8 million.

  • In prior years, Alumis' EBIT was -$300.75 million in FY2024 and -$158.17 million in FY2023.
  • The Q2 2026 figure stands as the lowest quarterly EBIT in data going back to Q2 2023.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) EBIT (Qtr)
1 Johnson & Johnson 638.12 Bn 556.64 Bn 17.26 Bn 7.14 Bn
2 AbbVie 462.60 Bn 435.75 Bn 12.70 Bn 6.43 Bn
3 Merck 358.70 Bn 313.13 Bn 12.21 Bn -584.00 Mn
4 Novartis Ag 272.16 Bn 228.03 Bn 11.24 Bn 4.75 Bn
5 Astrazeneca 250.36 Bn 223.92 Bn 12.86 Bn 3.16 Bn
6 Amgen 227.87 Bn 183.27 Bn 7.24 Bn 3.51 Bn
7 Gilead Sciences 184.97 Bn 159.08 Bn 6.22 Bn -10.39 Bn
8 Pfizer 162.61 Bn 109.56 Bn 10.94 Bn 4.27 Bn
9 Vertex Pharmaceuticals 132.45 Bn 104.46 Bn 2.84 Bn 1.25 Bn
10 Alumis 919.65 Mn -755.19 Mn - -148.86 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 -148.86 Mn
Dec 31, 2025 -96.45 Mn
Sep 30, 2025 -115.29 Mn
Jun 30, 2025 -140.54 Mn
Mar 31, 2025 -101.53 Mn
Dec 31, 2024 -98.62 Mn
Sep 30, 2024 -98.40 Mn
Jun 30, 2024 -56.14 Mn
Mar 31, 2024 -47.59 Mn
Dec 31, 2023 -40.13 Mn
Sep 30, 2023 -43.76 Mn
Jun 30, 2023 -37.62 Mn
API Access

Alumis EBIT API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=ebit&ticker=ALMS&period=max&api_key=YOUR_API_KEY